Home | Welcome to Contract Pharma   
Last Updated Monday, May 25 2015


Financial Report: AbbVie

Published April 26, 2013
1Q Revenues: $4.3 billion (+4%)
1Q Earnings: $968 million (+10%)
Comments: Growth was driven by Humira sales in the U.S. and internationally, up 16% to $2.2 billion. Synagis sales were $345 million, down 1%. AndroGel sales were up 3% to $240 million. TriCor/Trilipix sales were down 50% to $128 million due to the loss of exclusivity. Lupron sales were down 9% to $181 million.

blog comments powered by Disqus

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On